LACY VOGTMAN: Open Payments
NPI 1992735195 · PAPILLION, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 19 payments from 10 companies in 2025. Trend: 2023 $364 · 2024 $392 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $56 |
| Novo Nordisk Inc | 3 | $56 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Lilly USA, LLC | 2 | $35 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| SANOFI-AVENTIS U.S. LLC | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $15 |
Products named: QULIPTA, Wegovy, Auvelity, JARDIANCE, INSPIRE, Veozah, AIRSUPRA, TZIELD.
Industry payments across NE — which companies pay providers there.
